ClearSign Combustion Corporation — FY2012 Form 10-K
Business context and period: This annual report covers the fiscal year ended December 31, 2012. ClearSign was a development-stage company developing Electrodynamic Combustion Control (ECC), intended to improve combustion efficiency and emissions control. It had no operating revenue and had not commercially deployed the technology. The financial statements received an unqualified audit opinion; the auditor did not audit internal control over financial reporting.
Financial results and liquidity
| Metric | FY2012 | FY2011 |
|---|---|---|
| Revenue | $0 | $0 |
| Research and development expense | $1.184 million | $463,000 |
| General and administrative expense | $3.026 million | $2.516 million |
| Total operating expenses | $4.210 million | $2.979 million |
| Net loss | $4.189 million | $2.976 million |
| Net loss per share | $0.55 | $0.67 |
| Cash used in operating activities | $3.188 million | $1.688 million |
| Cash and cash equivalents at year-end | $8.027 million | $930,000 |
| Working capital at year-end | $7.643 million | $623,000 |
Margins are not meaningful because the company had no revenue. Net loss increased by $1.213 million as higher R&D and administrative spending more than offset the absence of the prior-year $1.0 million stock-based consulting charge to MDB Capital Group. FY2012 investing cash outflow was $868,000, including fixed assets and patent-related spending. Financing provided $11.153 million, primarily from the IPO. Year-end liabilities were $479,000, including $444,000 current liabilities; the promissory notes were paid off during 2012.
Material changes versus FY2011
- Operating expenses rose $1.231 million, with R&D expense increasing $721,000 as personnel and research activity expanded.
- G&A expense rose $510,000, reflecting higher personnel costs and $711,000 of public-company costs reported for 2012.
- Cash increased substantially following the April–May 2012 IPO: 3.45 million shares were sold at $4.00 per share, generating $13.8 million gross and approximately $11.2 million net cash proceeds.
- Research advanced from bench-scale work to testing that included a 1-million-BTU research furnace. The company reported filing 74 patent applications by year-end.
Outlook, risks and contingencies
- Management expected IPO proceeds to fund activities at least through April 2014. It anticipated annual capital expenditures of $0.5–$1.0 million and planned further R&D, intellectual-property protection and market development. These are management expectations, not revenue or profitability guidance.
- Commercial-scale performance remained unverified by an independent third party. The company planned full-scale site demonstrations and further commercialization work, but reported no definitive development or sponsorship agreements.
- Management warned that additional financing would likely be needed over time. If funding or technical progress is insufficient, operations may need to be scaled back or suspended.
- Key risks include technical scale-up and safety, customer adoption, competition from established suppliers, permitting, intellectual-property protection, and the company’s history of losses and negative operating cash flow. Accumulated deficit was $8.679 million.
- A former legal adviser asserted that a related partnership could acquire 25,250 shares at $0.02 per share under a 2007 engagement letter. ClearSign disputed the claim, citing a 2011 settlement among its defenses. The filing reports no other pending legal proceedings.
- About 3.168 million shares remained subject to IPO lock-up agreements set to expire April 24, 2013. Outstanding options and warrants, as well as potential future equity issuance, could dilute shareholders.
Important facts for investors to verify
- Whether ECC can demonstrate repeatable, independently verified performance and safety at commercial scale.
- Cash burn, actual spending against management’s April 2014 runway estimate, and the timing and terms of any additional financing.
- Progress toward customer-site demonstrations, signed partnerships, and revenue-generating commercial installations.
- Status and scope of patent applications, and resolution of the disputed share-acquisition claim.
- Potential dilution from options, warrants, equity awards, and shares becoming eligible for sale after lock-up expiration.